Bausch + Lomb and the Glaucoma Research Foundation (GRF) have partnered for the second annual Faces of Glaucoma campaign, aiming to raise awareness about glaucoma through diverse patient stories and educational initiatives. The campaign will run throughout Glaucoma Awareness Month in January and focuses on encouraging proactive eye health management.
Throughout the month, Bausch + Lomb and GRF will:
• Share personal stories of individuals and families living with glaucoma.
• Provide educational resources to help the public better understand glaucoma and its management.
Bausch + Lomb will support a fundraising campaign, pledging to match donations up to $20,000. The funds will directly support GRF’s groundbreaking research aimed at developing a cure for glaucoma.
The fundraising efforts will benefit Catalyst for a Cure, GRF’s flagship research initiative. This program brings together leading neuroscientists and glaucoma specialists to:
• Explore innovative glaucoma treatments.
• Accelerate progress toward vision restoration and an eventual cure.
Campaign materials are available online, offering:
• Lifestyle tips for glaucoma patients.
• Information on glaucoma prevention and risk management.
Andrew Stewart, President of Global Pharmaceuticals and International Consumer at Bausch + Lomb, emphasized the critical need for education:
“It’s estimated that half of people with glaucoma don’t know that they have it, demonstrating a need for continuing education and awareness efforts. In collaboration with Glaucoma Research Foundation, we aim to encourage people to take an active role in understanding and managing their risk, starting with seeing an eye doctor.”
The Faces of Glaucoma campaign represents a collaborative effort to increase awareness, fund vital research, and inspire proactive eye health management. By sharing stories and providing resources, Bausch + Lomb and GRF aim to empower individuals to take charge of their eye health and support the ongoing search for a cure.